Indefinite Delivery Contract 75D30125D20403
Award Date
12/31/24
Last Date to Order
2/28/26
Federal Agency
CDC Pittsburgh
Awardee
Sanofi Pasteur Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention (CDC) has awarded a single award Indefinite Delivery Contract (IDC) to Sanofi Pasteur Inc. for the procurement of pediatric influenza vaccines. The contract has a ceiling value of $149,625,000 and a period of performance from the date of award through February 28, 2023. Under this IDC, Sanofi Pasteur Inc. will provide between 100 and 50 million doses of pediatric influenza vaccine, which will be delivered to CDC distribution centers in Colorado...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc. as the prime contractor. The contract has a ceiling value of $144,427,500 and a period of performance from the award date of December 31, 2020 through February 28, 2022. The contract is for the provision of pediatric influenza vaccines, including a minimum order size of 100 doses and a maximum quantity of 50 million doses. The vaccines...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., a foreign-owned, for-profit pharmaceutical manufacturer of vaccines and medical supplies. The contract, valued at $163,144,080.00, is for the procurement of pediatric flu vaccines for the 2025-2026 fiscal year. The IDC is a multiple-award vehicle that will allow the CDC to issue task orders for the delivery of the required vaccines over the contract's period of...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian federal agency, to Sanofi Pasteur Inc., the prime contractor. The contract has a total ceiling value of $158,256,000 and a period of performance running through February 28, 2025. The purpose of this IDC is to provide pediatric influenza vaccines to the CDC for the 2024-2025 season. Sanofi Pasteur, as a manufacturer of vaccines and pharmaceutical products, will fulfill task...
The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a multiple award, indefinite delivery contract to Sanofi Pasteur Inc. to provide up to $1.683 billion in pediatric vaccines for the CDC's Vaccines for Children program. This 12-month contract enables the CDC and its Immunization Awardees to order a range of 20 standard pediatric vaccines including DTaP, IPV, Hepatitis A/B, Hib, HPV, MMR, MCV4, PCV13, Rotavirus, Td, Tdap, and Varicella vaccines....
This multiple award IDV was issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh to procure pediatric flu vaccines for 2023-2024. Sanofi Pasteur Inc. is the prime contractor awarded under the $153.88 million potential value contract. The IDV aims to deliver pediatric flu vaccines through task orders or price lists issued against the master agreement prior to the February 2024 ordering deadline. As the CDC works to prevent pediatric...
The federal contract IDV award was granted to Sanofi Pasteur Inc., a vaccine and pharmaceutical manufacturer, by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services, a civilian federal agency. The single-award Indefinite Delivery Contract, valued at up to $9,702,459.30, covers the delivery of various vaccine products and services to support public health preparedness and disease prevention missions of multiple government agencies. This includes seasonal and...
This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. to provide adult flu vaccines for the 2024-2025 season. The contract has a ceiling value of $64,529,958.50 and a period of performance through February 28, 2025. As the prime contractor, Sanofi Pasteur Inc. will leverage its pharmaceutical manufacturing and distribution capabilities to efficiently fulfill CDC's requirements for seasonal influenza vaccines to...
This indefinite delivery contract, awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc., is for the provision of vaccines for the Vaccines for Children (VFC) program. Valued at up to $2,413,810,030, the 5-year contract (4/1/2023 - 3/31/2024) is a multiple award vehicle that allows the CDC to issue task orders for a variety of vaccine products and related services from the prime contractor. Sanofi Pasteur, as a leading global vaccine manufacturer, will leverage...
This Indefinite Delivery Contract (IDC) awarded by the Centers for Disease Control and Prevention (CDC) to Sanofi Pasteur Inc. is for the procurement of pediatric COVID-19 vaccines. The $23,763,000 multiple-award contract has an ultimate completion date of May 31, 2026. As a leading global vaccine manufacturer, Sanofi Pasteur provides a wide range of immunization products to various federal agencies, including seasonal and pandemic influenza vaccines, pediatric vaccines, adult vaccines, and...